tasocitinib

Showing 1 posts of 1 posts found.

Late stage trial boost for Pfizer’s arthritis drug tasocitinib

November 8, 2010
JAK inhibitors, Pfizer, arthritis, tasocitinib

Pfizer’s rheumatoid arthritis treatment tasocitinib has met its two of its three primary endpoints in a phase III trial. Primary …

The Gateway to Local Adoption Series

Latest content